Ray Dalio’s AbbVie ABBV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $111M | Buy |
598,292
+493,340
| +470% | +$91.6M | 0.45% | 51 |
|
|
2025
Q1 | $22M | Sell |
104,952
-181,411
| -63% | -$38M | 0.1% | 168 |
|
|
2024
Q4 | $50.9M | Buy |
286,363
+81,791
| +40% | +$14.5M | 0.23% | 81 |
|
|
2024
Q3 | $40.4M | Sell |
204,572
-83,953
| -29% | -$16.6M | 0.23% | 81 |
|
|
2024
Q2 | $49.5M | Sell |
288,525
-161,254
| -36% | -$27.7M | 0.26% | 64 |
|
|
2024
Q1 | $81.9M | Sell |
449,779
-157,114
| -26% | -$28.6M | 0.41% | 47 |
|
|
2023
Q4 | $94.1M | Buy |
606,893
+30,933
| +5% | +$4.79M | 0.53% | 41 |
|
|
2023
Q3 | $85.9M | Sell |
575,960
-58,345
| -9% | -$8.7M | 0.52% | 39 |
|
|
2023
Q2 | $85.5M | Buy |
634,305
+222,875
| +54% | +$30M | 0.53% | 40 |
|
|
2023
Q1 | $65.6M | Buy |
411,430
+381,328
| +1,267% | +$60.8M | 0.4% | 54 |
|
|
2022
Q4 | $4.86M | Sell |
30,102
-182,648
| -86% | -$29.5M | 0.03% | 366 |
|
|
2022
Q3 | $28.6M | Buy |
212,750
+130,900
| +160% | +$17.6M | 0.14% | 125 |
|
|
2022
Q2 | $12.5M | Buy |
81,850
+6,334
| +8% | +$970K | 0.05% | 287 |
|
|
2022
Q1 | $12.2M | Buy |
75,516
+33,661
| +80% | +$5.46M | 0.05% | 253 |
|
|
2021
Q4 | $5.67M | Sell |
41,855
-33,241
| -44% | -$4.5M | 0.03% | 269 |
|
|
2021
Q3 | $8.1M | Buy |
75,096
+22,491
| +43% | +$2.43M | 0.04% | 223 |
|
|
2021
Q2 | $5.93M | Buy |
+52,605
| New | +$5.93M | 0.04% | 303 |
|
|
2021
Q1 | – | Sell |
-25,294
| Closed | -$2.71M | – | 458 |
|
|
2020
Q4 | $2.71M | Buy |
+25,294
| New | +$2.71M | 0.02% | 265 |
|